HCA Healthcare Inc (HCA) SVP Sells $3,902,833.48 in Stock

Share on StockTwits

HCA Healthcare Inc (NYSE:HCA) SVP Victor L. Campbell sold 28,084 shares of the company’s stock in a transaction dated Monday, February 11th. The shares were sold at an average price of $138.97, for a total transaction of $3,902,833.48. Following the transaction, the senior vice president now directly owns 231,493 shares of the company’s stock, valued at approximately $32,170,582.21. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

HCA stock opened at $140.89 on Thursday. The firm has a market capitalization of $48.36 billion, a P/E ratio of 14.42, a PEG ratio of 1.16 and a beta of 0.80. HCA Healthcare Inc has a 12-month low of $93.03 and a 12-month high of $147.42.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Tuesday, January 29th. The company reported $2.99 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.59 by $0.40. HCA Healthcare had a net margin of 8.11% and a negative return on equity of 91.25%. The business had revenue of $12.27 billion during the quarter, compared to analyst estimates of $12.10 billion. During the same period in the prior year, the firm posted $2.12 earnings per share. The company’s quarterly revenue was up 6.2% on a year-over-year basis. Equities analysts expect that HCA Healthcare Inc will post 10.02 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 29th. Shareholders of record on Friday, March 1st will be given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 1.14%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.35. The ex-dividend date of this dividend is Thursday, February 28th. HCA Healthcare’s dividend payout ratio (DPR) is presently 14.33%.

Several brokerages have recently commented on HCA. SunTrust Banks increased their target price on shares of HCA Healthcare to $175.00 and gave the company a “buy” rating in a report on Wednesday, January 30th. Stephens started coverage on HCA Healthcare in a report on Monday, January 14th. They set an “overweight” rating and a $143.00 price target on the stock. Jefferies Financial Group boosted their price target on HCA Healthcare from $155.00 to $158.00 and gave the stock a “buy” rating in a research note on Wednesday, October 31st. Oppenheimer increased their target price on shares of HCA Healthcare from $142.00 to $150.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 30th. Finally, Zacks Investment Research upgraded shares of HCA Healthcare from a “hold” rating to a “buy” rating and set a $151.00 price target on the stock in a research note on Monday, November 26th. Two research analysts have rated the stock with a sell rating, two have given a hold rating and eighteen have issued a buy rating to the company’s stock. HCA Healthcare has an average rating of “Buy” and an average price target of $148.43.

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Chicago Equity Partners LLC boosted its position in shares of HCA Healthcare by 4.6% during the fourth quarter. Chicago Equity Partners LLC now owns 1,841 shares of the company’s stock worth $229,000 after acquiring an additional 81 shares during the last quarter. Quadrant Capital Group LLC boosted its position in HCA Healthcare by 11.2% during the 4th quarter. Quadrant Capital Group LLC now owns 847 shares of the company’s stock valued at $93,000 after purchasing an additional 85 shares during the period. Advisor Partners LLC raised its position in HCA Healthcare by 2.3% during the fourth quarter. Advisor Partners LLC now owns 5,079 shares of the company’s stock valued at $632,000 after buying an additional 113 shares during the period. Commonwealth Bank of Australia raised its holdings in shares of HCA Healthcare by 4.6% in the 4th quarter. Commonwealth Bank of Australia now owns 2,783 shares of the company’s stock worth $344,000 after buying an additional 122 shares in the last quarter. Finally, Whitener Capital Management Inc. raised its stake in HCA Healthcare by 50.0% during the 4th quarter. Whitener Capital Management Inc. now owns 474 shares of the company’s stock worth $58,000 after buying an additional 158 shares during the period. 72.85% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: “HCA Healthcare Inc (HCA) SVP Sells $3,902,833.48 in Stock” was originally published by Equities Focus and is the sole property of of Equities Focus. If you are reading this news story on another publication, it was copied illegally and republished in violation of international trademark & copyright legislation. The legal version of this news story can be viewed at https://www.equitiesfocus.com/2019/02/14/hca-healthcare-inc-hca-svp-sells-3902833-48-in-stock.html.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Further Reading: Is it better to buy a fund with a higher or lower NAV?

Insider Buying and Selling by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply